Skip to main content
OpenTrials
Completed

NCT Number: NCT02266069

PROject - Supportive and Palliative Care and INnOvation - Antwerp (Pro-Spinoza)

It is important to provide high quality palliative care to all patients with a non-curable and life-limiting condition. The Care Pathway for Primary Palliative Care (CPPPC) provides tools for health care professionals to help them delivering palliative care timely and accurately.This study investigates whether the implementation of the CPPPC really helps to improve patients' lifes.

Completed

Looking for future studies?

Notify Me

Key information

Age range

45 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Reliance, Mons, Hainaut, Belgium

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • identified as a palliative care patient using the Surprise Question "Would you, as a family doctor, be surprised if this patient would die in the next 12 months?". If the answer is 'no', the patient is eligible for the study.

Exclusion criteria

  • not having signed the informed consent.

Treatment and study plan

Care Pathway for Primary Palliative Care

Other

Early identification of palliative care patients, anticipatory care planning, systematic symptom assessment, interdisciplinary collaboration, rigorous follow-up of the functional status of the patient and giving attention to the informal care givers.

Other names: CPPPC

Primary outcomes

  1. percentage of deaths occurred in the hospital (of patients per family doctor/per research cluster)

    Time frame: 6 months

    The hypothesis is that the CPPPC reduces the percentage of deaths occurred in the hospital

Secondary outcomes

  1. cost of health care consumption in the last year of life (of patients per family doctor/per research cluster)

    Time frame: 6 months

    The hypothesis is that the CPPPC reduces the cost of health care consumption in the last year of life

  2. consumption of antibiotics in the last year of life (of patients per family doctor/per research cluster)

    Time frame: 6 months

    The hypothesis is that the CPPPC reduces the consumption of antibiotics in the last year of life

  3. consumption of pain killers in the last year of life (of patients per family doctor/per research cluster)

    Time frame: 6 months

    The hypothesis is that the CPPPC augments the consumption of pain killers in the last year of life

  4. consumption of (invasive) diagnostic and therapeutic procedures in the last year of life (of patients per family doctor/per research cluster)

    Time frame: 6 months

    The hypothesis is that the CPPPC reduces the consumption of (invasive) diagnostic and therapeutic procedures in the last year of life

Sponsors and collaborators

Lead sponsor

Bert Leysen

Other

Collaborators

  • Intermutualistic Agency
  • National Institute for Health and Disability Insurance, Belgium

Registry information

Official study title

Implementation of the Care Pathway for Primary Palliative Care in Five Research Clusters in Belgium

Acronym: pro-Spinoza

Important dates

Study start
2014
Primary completion
2016
Study completion
2016
First posted
Oct 16, 2014
Registry last updated
Nov 29, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.